// App-Quantinova.ai

BIOM-60 : BIOMARKER EVALUATION FOR IMIPRIDONE ONC206 REVEALS ClpP, ATF4, MYC, EGFR and HIF1 AS KEY PREDICTORS OF ANTI-CANCER EFFICACY

Researchers

Presenter

  • Sara Morrow

Principal Investigators

  • Mathew Garnett

  • Ultan McDermott

  • Cyril Benes

  • Joshua Allen

  • Varun Prabhu

Medical Centers

  • Oncoceutics, Inc., Philadelphia, PA, USA

  • Sanger Institute, Hinxton, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Gliomas

Biomarkers

  • cMYC

  • Epidermal growth factor receptor

  • Hypoxia-inducible factor-1

Drug/Treatment

  • Dopamine hydrochloride

  • TIC 10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved